Randomized Trial of Consolidation Targeted Adjuvant Therapy with Encorafenib and Cetuximab Versus Usual Care for Patients with Stage II/III BRAF V600E Colon Cancer
Pre Registration QOLs - To be completed after consent, prior to registration.
A022004 will be closed to accrual, effective December 20, 2024.